Lynn Tyler of the Indianapolis office authored "Classen Immunotherapies v. Elan: The Scope of the Patent Infringement Exemption in 35 U.S.C. 271 § (e)(1)" for the Food and Drug Law Institute (FDLI). The article was distributed to more than 750 attendees at the FDLI's recent annual meeting. At the meeting, Lynn led a table talk discussion on the topic of diagnostic method patents.
Newsletters
Food and Drug Law Institute - "Classen Immunotherapies v. Elan: The Scope of the Patent Infringement Exemption in 35 U.S.C. 271 § (e)(1)"
May 13, 2016
Indianapolis
RELATED PEOPLE
Partner
Food, Drug and Device Practice Chair
F
317-231-7433
×
Subscribe
Do you want to receive more valuable insights directly in your inbox? Visit our subscription center and let us know what you're interested in learning more about.
View Subscription Center
